Serina Therapeutics, Inc.
SER
$5.70
-$0.15-2.56%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.74M | 1.41M | -374.00K | -9.44M | 1.05M |
| Total Depreciation and Amortization | 56.00K | 56.00K | 57.00K | 25.00K | 6.00K |
| Total Amortization of Deferred Charges | 8.00K | 8.00K | 307.00K | 22.00K | -- |
| Total Other Non-Cash Items | -1.74M | -5.38M | -3.21M | 7.12M | -686.00K |
| Change in Net Operating Assets | -172.00K | 943.00K | -4.79M | 698.00K | -250.00K |
| Cash from Operations | -4.59M | -2.96M | -8.01M | -1.58M | 121.00K |
| Capital Expenditure | -5.00K | -3.00K | 0.00 | -14.00K | -70.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.00K | -3.00K | 0.00 | -14.00K | -70.00K |
| Total Debt Issued | 110.00K | 8.00K | 525.00K | 2.40M | 0.00 |
| Total Debt Repaid | -1.00K | -8.00K | -146.00K | -13.00K | -13.00K |
| Issuance of Common Stock | 4.92M | 86.00K | 4.99M | 4.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 337.00K | -- |
| Cash from Financing | 5.03M | 86.00K | 5.37M | 2.73M | -13.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 437.00K | -2.88M | -2.64M | 1.14M | 38.00K |